1 EXHIBIT 10.20 NORTHWEST BIOTHERAPEUTICS, INC. AMENDED AND RESTATED INVESTORS' RIGHTS AGREEMENT

1
EXHIBIT 10.20

NORTHWEST BIOTHERAPEUTICS, INC.

AMENDED AND RESTATED INVESTORS' RIGHTS AGREEMENT

MARCH ___, 1999

TABLE OF CONTENTS

Page
----

1. Registration Rights................................................................1

1.1 Definitions.................................................................2
1.2 Company Registration........................................................2
1.3 Obligations of the Company..................................................3
1.4 Furnish Information.........................................................4
1.5 Expenses of Registration....................................................4
1.6 Underwriting Requirements...................................................4
1.7 Delay of Registration.......................................................5
1.8 Indemnification.............................................................5
1.9 Reports Under Securities Exchange Act of 1934...............................7
1.10 Assignment of Registration Rights...........................................8
1.11 "Market Stand-Off" Agreement................................................8
1.12 Termination of Registration Rights..........................................9

2. Covenants of the Company...........................................................9

2.1 Delivery of Financial Statements............................................9
2.2 Inspection..................................................................9
2.3 Termination of Covenants...................................................10

3. Covenants of Investors............................................................10

4. Miscellaneous.....................................................................10

4.1 Successors and Assigns......................................................10
4.2 Amendments and Waivers......................................................10
4.3 Notices.....................................................................10
4.4 Severability...............................................................101
4.5 Governing Law...............................................................11
4.6 Counterparts................................................................11
4.7 Titles and Subtitles........................................................11
4.8 Aggregation of Stock........................................................11

i
3

NORTHWEST BIOTHERAPEUTICS, INC.

AMENDED AND RESTATED INVESTORS' RIGHTS AGREEMENT

This Investors' Rights Agreement (the "Agreement") is made as of the
_____ day of March, 1999, by and among Northwest Biotherapeutics, Inc., a
Delaware corporation (the "Company"), the Series A Preferred Stock investors
listed on Exhibit A hereto, each of which is herein referred to as a "Series A
Investor," the Series B Preferred Stock investors listed on Exhibit B hereto,
each of which is herein referred to as a "Series B Investor," and the Series C
Preferred Stock investors listed on Exhibit C hereto, each of which is herein
referred to as a "Series C Investor." The Series A Investors, Series B Investors
and Series C Investors are herein individually referred to as an "Investor" and
collectively referred to as the "Investors."

RECITALS

A. The Company, the Series A Investors and the Series B Investors
entered into an Investors' Rights Agreement dated as of September 15, 1998 (the
"Original Rights Agreement") in order to provide such Investor with certain
rights to receive or inspect information pertaining to the Company.

B. The Series C Investors have subscribed for shares of Series C
Preferred Stock pursuant to the Confidential Private Placement Memorandum dated
November 16, 1998 and the subscription agreement related thereto (collectively,
the "Subscription Agreements"). A condition to the Series C Investors'
obligations under the Subscription Agreements is that the Company, the Series A
Investors, the Series B Investors and the Series C Investors enter into this
Agreement in order to provide the Investors with (i) certain rights to register
shares of the Company's Common Stock issuable upon conversion of the Preferred
Stock held by the Investors and (ii) certain rights to receive or inspect
information pertaining to the Company.

C. The Company, the Series A Investors and the Series B Investors desire
to induce the Series C Investors to purchase shares of Series C Preferred Stock
pursuant to the Subscription Agreements by agreeing to the terms and conditions
set forth herein.

D. The Series A Investors and the Series B Investors are holders of at
least a majority of the outstanding Registrable Securities (as defined below)
and desire to terminate the Original Rights Agreement in its entirety and accept
the rights created pursuant to this Agreement in lieu of the rights granted to
them under the Original Rights Agreement.

AGREEMENT

The parties hereby agree as follows:

1. REGISTRATION RIGHTS. The Company and the Investors covenant and agree
as follows:

1.1 DEFINITIONS. For purposes of this Section 1:

(a) The terms "register," "registered," and "registration" refer
to a registration effected by preparing and filing a registration statement or
similar document in compliance with the Securities Act of 1933, as amended (the
"Securities Act"), and the declaration or ordering of effectiveness of such
registration statement or document;

(b) The term "Registrable Securities" means (i) the shares of
Common Stock issuable or issued upon conversion of the Series A Preferred Stock,
Series B Preferred Stock or Series C Preferred Stock of the Company and (ii) any
other shares of Common Stock of the Company issued as (or issuable upon the
conversion or exercise of any warrant, right or other security which is issued
as) a dividend or other distribution with respect to, or in exchange for or in
replacement of, the shares listed in (i); provided, however, that the foregoing
definition shall exclude in all cases any Registrable Securities sold by a
person in a transaction in which his or her rights under this Agreement are not
assigned. Notwithstanding the foregoing, Common Stock or other securities shall
only be treated as Registrable Securities if and so long as they have not been
(A) sold to or through a broker or dealer or underwriter in a public
distribution or a public securities transaction, or (B) sold in a transaction
exempt from the registration and prospectus delivery requirements of the
Securities Act under Section 4(1) thereof so that all transfer restrictions, and
restrictive legends with respect thereto, if any, are removed upon the
consummation of such sale;

(c) The number of shares of "Registrable Securities then
outstanding" shall be determined by the number of shares of Common Stock
outstanding which are, and the number of shares of Common Stock issuable
pursuant to then exercisable or convertible securities which are, Registrable
Securities;

(d) The term "Holder" means any person owning or having the right
to acquire Registrable Securities or any assignee thereof in accordance with
Section 1.10 of this Agreement;

(e) The term "SEC" means the Securities and Exchange Commission;
and

(f) The term "IPO" means a firm commitment underwritten public
offering by the Company of shares of its Common Stock pursuant to a registration
statement on Form S-I under the Securities Act.

1.2 COMPANY REGISTRATION. If (but without any obligation to do so)
the Company proposes to register (including for this purpose a registration
effected by the Company for stockholders other than the Holders) any of its
stock under the Securities Act in connection with the public offering of such
securities solely for cash (other than a registration relating solely to the
sale of securities to participants in a Company stock plan or a transaction
covered by Rule 145 under the Securities Act, a registration in which the only
stock being registered is Common Stock issuable upon conversion of debt
securities which are also being registered, or any registration on any form
which does not include substantially the same information as would

2
5

be required to be included in a registration statement covering the sale of the
Registrable Securities), the Company shall, at such time, promptly give each
Holder written notice of such registration. Upon the written request of each
Holder given within twenty (20) days after mailing of such notice by the Company
in accordance with Section 4.3, the Company shall, subject to the provisions of
Section 1.6, cause to be registered under the Securities Act all of the
Registrable Securities that each such Holder has requested to be registered.

1.3 OBLIGATIONS OF THE COMPANY. Whenever required under this Section
1 to effect the registration of any Registrable Securities, the Company shall,
as expeditiously as reasonably possible:

(a) Prepare and file with the SEC a registration statement with
respect to such Registrable Securities and use its best efforts to cause such
registration statement to become effective, and, upon the request of the Holders
of a majority of the Registrable Securities registered thereunder, keep such
registration statement effective for up to one hundred twenty (120) days. The
Company shall not be required to file, cause to become effective or maintain the
effectiveness of any registration statement that contemplates a distribution of
securities on a delayed or continuous basis pursuant to Rule 415 under the
Securities Act.

(b) Prepare and file with the SEC such amendments and supplements
to such registration statement and the prospectus used in connection with such
registration statement as may be necessary to comply with the provisions of the
Securities Act with respect to the disposition of all securities covered by such
registration statement for up to one hundred twenty (120) days.

(c) Furnish to the Holders such numbers of copies of a
prospectus, including a preliminary prospectus, in conformity with the
requirements of the Securities Act, and such other documents as they may
reasonably request in order to facilitate the disposition of Registrable
Securities owned by them.

(d) Use its best efforts to register and qualify the securities
covered by such registration statement under such other securities or Blue Sky
laws of such jurisdictions as shall be reasonably requested by the Holders,
provided that the Company shall not be required in connection therewith or as a
condition thereto to qualify to do business or to file a general consent to
service of process in any such states or jurisdictions.

(e) In the event of any underwritten public offering, enter into
and perform its obligations under an underwriting agreement, in usual and
customary form, with the managing underwriter of such offering. Each Holder
participating in such underwriting shall also enter into and perform its
obligations under such an agreement.

(f) Notify each Holder of Registrable Securities covered by such
registration statement at any time when a prospectus relating thereto is
required to be delivered under the Securities Act of the happening of any event
as a result of which the prospectus included in such registration statement, as
then in effect, includes an untrue statement of a material fact or omits to
state a material fact required to be stated therein or necessary to make

3
6

the statements therein not misleading in the light of the circumstances then
existing, such obligation to continue for one hundred twenty (120) days.

(g) Cause all such Registrable Securities registered pursuant
hereunder to be listed on each securities exchange on which similar securities
issued by the Company are then listed.

(h) Provide a transfer agent and registrar for all Registrable
Securities registered pursuant hereunder and a CUSIP number for all such
Registrable Securities, in each case not later than the effective date of such
registration.

(i) Use its best efforts to furnish, at the request of any Holder
requesting registration of Registrable Securities pursuant to this Section 1, on
the date that such Registrable Securities are delivered to the underwriters for
sale in connection with a registration pursuant to this Section 1, if such
securities are being sold through underwriters, or, if such securities are not
being sold through underwriters, on the date that the registration statement
with respect to such securities becomes effective, (i) an opinion, dated such
date, of the counsel representing the Company for the purposes of such
registration, in form and substance as is customarily given to underwriters in
an underwritten public offering, addressed to the underwriters, if any, and to
the Holders requesting registration of Registrable Securities and (ii) a letter
dated such date, from the independent certified public accountants of the
Company, in form and substance as is customarily given by independent certified
public accountants to underwriters in an underwritten public offering, addressed
to the underwriters, if any, and to the Holders requesting registration of
Registrable Securities.

1.4 FURNISH INFORMATION. It shall be a condition precedent to the
obligations of the Company to take any action pursuant to this Section 1 with
respect to the Registrable Securities of any selling Holder that such Holder
shall furnish to the Company such information regarding itself, the Registrable
Securities held by it, and the intended method of disposition of such securities
as shall be required to effect the registration of such Holder's Registrable
Securities.

1.5 EXPENSES OF REGISTRATION. All expenses for each Holder (which
right may be assigned as provided in Section 1.10), other than underwriting
discounts and commissions incurred in connection with the first four (in the
aggregate) registrations, filings or qualifications of Registrable Securities
pursuant to Section 1.2, including (without limitation) all registration,
filing, and qualification fees, printers' and accounting fees, fees and
disbursements of counsel for the Company and the reasonable fees and
disbursements of one counsel for the selling Holder or Holders selected by them
with the approval of the Company, which approval shall not be unreasonably
withheld, shall be borne by the Company.

1.6 UNDERWRITING REQUIREMENTS. In connection with any offering
involving an underwriting of shares of the Company's capital stock, the Company
shall not be required under Section 1.2 to include any of the Holders'
securities in such underwriting unless they accept the terms of the underwriting
as agreed upon between the Company and the underwriters selected by it (or by
other persons entitled to select the underwriters), and then only in such

4
7

quantity as the underwriters determine in their sole discretion will not
jeopardize the success of the offering by the Company. If the total amount of
securities, including Registrable Securities, requested by stockholders to be
included in such offering exceeds the amount of securities sold other than by
the Company that the underwriters determine in their sole discretion is
compatible with the success of the offering, then the Company shall be required
to include in the offering only that number of such securities, including
Registrable Securities, which the underwriters determine in their sole
discretion will not jeopardize the success of the offering (the securities so
included to be apportioned pro rata among the selling stockholders according to
the total amount of securities entitled to be included therein owned by each
selling stockholder or in such other proportions as shall mutually be agreed to
by such selling stockholders) but in no event shall the amount of securities of
the selling Holders included in the offering be reduced below twenty percent
(20%) of the total amount of securities included in such offering, unless such
offering is the initial public offering of the Company's securities, in which
case the selling stockholders may be excluded if the underwriters make the
determination described above and no other stockholder's securities are
included. For purposes of the preceding parenthetical concerning apportionment,
for any selling stockholder which is a holder of Registrable Securities and
which is a partnership or corporation, the partners, retired partners and
stockholders of such holder, or the estates and family members of any such
partners and retired partners and any trusts for the benefit of any of the
foregoing persons shall be deemed to be a single "selling stockholder," and any
pro-rata reduction with respect to such "selling stockholder" shall be based
upon the aggregate amount of shares carrying registration rights owned by all
entities and individuals included in such "selling stockholder," as defined in
this sentence.

1.7 DELAY OF REGISTRATION. No Holder shall have any right to obtain
or seek an injunction restraining or otherwise delaying any such registration as
the result of any controversy that might arise with respect to the
interpretation or implementation of this Section 1.

1.8 INDEMNIFICATION. In the event any Registrable Securities are
included in a registration statement under this Section 1:

(a) To the extent permitted by law, the Company will indemnify
and hold harmless each Holder, any underwriter (as defined in the Securities
Act) for such Holder and each person, if any, who controls such Holder or
underwriter within the meaning of the Securities Act or the Securities Exchange
Act of 1934, as amended (the "Exchange Act"), against any losses, claims,
damages, or liabilities (joint or several) to which they may become subject
under the Securities Act, the Exchange Act or other federal or state law,
insofar as such losses, claims, damages, or liabilities (or actions in respect
thereof) arise out of or are based upon any of the following statements,
omissions or violations (collectively a "Violation"): (i) any untrue statement
or alleged untrue statement of a material fact contained in such registration
statement, including any preliminary prospectus or final prospectus contained
therein or any amendments or supplements thereto, (ii) the omission or alleged
omission to state therein a material fact required to be stated therein, or
necessary to make the statements therein not misleading, or (iii) any violation
or alleged violation by the Company of the Securities Act, the Exchange Act, any
state securities law or any rule or regulation promulgated under the Securities
Act, the Exchange Act or any state securities law; and the Company will pay to
each such

5
8

Holder, underwriter or controlling person, as incurred, any legal or other
expenses reasonably incurred by them in connection with investigating or
defending any such loss, claim, damage, liability, or action; provided, however,
that the indemnity agreement contained in this subsection 1.8(a) shall not apply
to amounts paid in settlement of any such loss, claim, damage, liability, or
action if such settlement is effected without the consent of the Company (which
consent shall not be unreasonably withheld), nor shall the Company be liable to
any Holder, underwriter or controlling person for any such loss, claim, damage,
liability, or action to the extent that it arises out of or is based upon a
Violation which occurs in reliance upon and in conformity with written
information furnished expressly for use in connection with such registration by
any such Holder, underwriter or controlling person.

(b) To the extent permitted by law, each selling Holder will
indemnify and hold harmless the Company, each of its directors, each of its
officers who has signed the registration statement, each person, if any, who
controls the Company within the meaning of the Securities Act, any underwriter,
any other Holder selling securities in such registration statement and any
controlling person of any such underwriter or other Holder, against any losses,
claims, damages, or liabilities (joint or several) to which any of the foregoing
persons may become subject, under the Securities Act, the Exchange Act or other
federal or state law, insofar as such losses, claims, damages, or liabilities
(or actions in respect thereto) arise out of or are based upon any Violation, in
each case to the extent (and only to the extent) that such Violation occurs in
reliance upon and in conformity with written information furnished by such
Holder expressly for use in connection with such registration; and each such
Holder will pay, as incurred, any legal or other expenses reasonably incurred by
any person intended to be indemnified pursuant to this subsection 1.8(b), in
connection with investigating or defending any such loss, claim, damage,
liability, or action; provided, however, that the indemnity agreement contained
in this subsection 1.8(b) shall not apply to amounts paid in settlement of any
such loss, claim, damage, liability or action if such settlement is effected
without the consent of the Holder, which consent shall not be unreasonably
withheld; provided, that in no event shall any indemnity under this subsection
1.8(b) exceed the net proceeds from the offering received by such Holder, except
in the case of willful fraud by such Holder.

(c) Promptly after receipt by an indemnified party under this
Section 1.8 of notice of the commencement of any action (including any
governmental action), such indemnified party will, if a claim in respect thereof
is to be made against any indemnifying party under this Section 1.8, deliver to
the indemnifying party a written notice of the commencement thereof and the
indemnifying party shall have the right to participate in, and, to the extent
the indemnifying party so desires, jointly with any other indemnifying party
similarly noticed, to assume the defense thereof with counsel mutually
satisfactory to the parties; provided, however, that an indemnified party
(together with all other indemnified parties which may be represented without
conflict by one counsel) shall have the right to retain one separate counsel,
with the reasonable fees and expenses to be paid by the indemnifying party, if
representation of such indemnified party by the counsel retained by the
indemnifying party would be inappropriate due to actual or potential differing
interests between such indemnified party and any other party represented by such
counsel in such proceeding. The failure to deliver written notice to the
indemnifying party within a reasonable time of the commencement of any such
action, if prejudicial to its ability to defend such action, shall relieve such
indemnifying

6
9

party of any liability to the indemnified party under this Section 1.8, but the
omission so to deliver written notice to the indemnifying party will not relieve
it of any liability that it may have to any indemnified party otherwise than
under this Section 1.8.

(d) If the indemnification provided for in this Section 1.8 is
held by a court of competent jurisdiction to be unavailable to an indemnified
party with respect to any loss, liability, claim, damage or expense referred to
therein, then the indemnifying party, in lieu of indemnifying such indemnified
party hereunder, shall contribute to the amount paid or payable by such
indemnified party as a result of such loss, liability, claim, damage, or expense
in such proportion as is appropriate to reflect the relative fault of the
indemnifying party on the one hand and of the indemnified party on the other in
connection with the statements or omissions that resulted in such loss,
liability, claim, damage or expense as well as any other relevant equitable
considerations; provided, that in no event shall any contribution by a Holder
under this Subsection 1.8(d) exceed the net proceeds from the offering received
by such Holder, except in the case of willful fraud by such Holder. The relative
fault of the indemnifying party and of the indemnified party shall be determined
by reference to, among other things, whether the untrue or alleged untrue
statement of a material fact or the omission to state a material fact relates to
information supplied by the indemnifying party or by the indemnified party and
the parties' relative intent, knowledge, access to information, and opportunity
to correct or prevent such statement or omission.

(e) Notwithstanding the foregoing, to the extent that the
provisions on indemnification and contribution contained in the underwriting
agreement entered into in connection with the underwritten public offering are
in conflict with the foregoing provisions, the provisions in the underwriting
agreement shall control.

(f) The obligations of the Company and Holders under this Section
1.8 shall survive the completion of any offering of Registrable Securities in a
registration statement under this Section 1, and otherwise.

1.9 REPORTS UNDER SECURITIES EXCHANGE ACT OF 1934. With a view to
making available to the Holders the benefits of Rule 144 promulgated under the
Securities Act and any other rule or regulation of the SEC that may at any time
permit a Holder to sell securities of the Company to the public without
registration, the Company agrees to:

(a) make and keep public information available, as those terms
are understood and defined in SEC Rule 144, at all times after ninety (90) days
after the effective date of the first registration statement filed by the
Company for the offering of its securities to the general public so long as the
Company remains subject to the periodic reporting requirements under Sections 13
or 15(d) of the Exchange Act;

(b) file with the SEC in a timely manner all reports and other
documents required of the Company under the Securities Act and the Exchange Act;
and

(c) furnish to any Holder, so long as the Holder owns any
Registrable Securities, forthwith upon request (i) a written statement by the
Company that it has complied

7
10

with the reporting requirements of SEC Rule 144 (at any time after ninety (90)
days after the effective date of the first registration statement filed by the
Company), the Securities Act and the Exchange Act (at any time after it has
become subject to such reporting requirements), (ii) a copy of the most recent
annual or quarterly report of the Company and such other reports and documents
so filed by the Company, and (iii) such other information as may be reasonably
requested in availing any Holder of any rule or regulation of the SEC which
permits the selling of any such securities without registration or pursuant to
such form.

1.10 ASSIGNMENT OF REGISTRATION RIGHTS. The rights to cause the
Company to register Registrable Securities pursuant to this Section I may be
assigned (but only with all related obligations) by a Holder to a transferee or
assignee of at least 100,000 shares of such securities unless such transferee or
assignee is a partner or affiliate of the Holder in which case no minimum
shareholdings are required, or all of such transferring Holder's securities, if
less than 100,000 shares, provided the Company is promptly furnished with
written notice of the name and address of such transferee or assignee and the
securities with respect to which such registration rights are being assigned;
and provided, further, that such assignment shall be effective only if
immediately following such transfer the further disposition of such securities
by the transferee or assignee is restricted under the Securities Act. For the
purposes of determining the number of shares of Registrable Securities held by a
transferee or assignee, the holdings of transferees and assignees of a
partnership who are partners or retired partners of such partnership (including
spouses and ancestors, lineal descendants and siblings of such partners or
spouses who acquire Registrable Securities by gift, will or intestate
succession) shall be aggregated together and with the partnership; provided that
all assignees and transferees who would not qualify individually for assignment
of registration rights shall have a single attorney-in-fact for the purpose of
exercising any rights, receiving notices or taking any action under Section 1.

1.11 "MARKET STAND-OFF" AGREEMENT. Each Holder hereby agrees that,
during the period of duration (up to 180 days in the case of an initial public
offering and up to 90 days in the case of all other public offerings) specified
by the Company and an underwriter of Common Stock or other securities of the
Company, following the effective date of a registration statement of the Company
filed under the Securities Act, it shall not, to the extent requested by the
Company and such underwriter, directly or indirectly sell, offer to sell,
contract to sell (including, without limitation, any short sale), grant any
option to purchase or otherwise transfer or dispose of (other than to donees who
agree to be similarly bound) any securities of the Company held by it at any
time during such period except Common Stock included in such registration;
provided, however, that all officers and directors of the Company enter into
similar agreements.

In order to enforce the foregoing covenant, the Company may impose
stop-transfer instructions with respect to the Registrable Securities of each
Holder (and the shares or securities of every other person subject to the
foregoing restriction) until the end of such period, and each Holder agrees
that, if so requested, such Holder will execute an agreement in the form
provided by the underwriter containing terms which are essentially consistent
with the provisions of this Section 1.11.

8
11

Notwithstanding the foregoing, the obligations described in this
Section 1.11 shall not apply to a registration relating solely to employee
benefit plans on Form S-1 or Form S-8 or similar forms which may be promulgated
in the future, or a registration relating solely to an SEC Rule 145 transaction
on Form S-4 or similar forms which may be promulgated in the future.

1.12 TERMINATION OF REGISTRATION RIGHTS. No Holder shall be entitled
to exercise any right provided for in this Section 1 after the earlier of (i)
five (5) years following the consummation of an IPO, or (ii) such time as Rule
144 or another similar exemption under the Securities Act is available for the
sale of all of such Holder's shares during a three (3)-month period without
registration.

2. COVENANTS OF THE COMPANY.

2.1 DELIVERY OF FINANCIAL STATEMENTS. The Company shall deliver to
each Holder of at least 100,000 shares of Registrable Securities (other than a
Holder reasonably deemed by the Company to be a competitor of the Company):

(a) as soon as practicable, but in any event within ninety (90)
days after the end of each fiscal year of the Company, an income statement for
such fiscal year, a balance sheet of the Company and statement of stockholder's
equity as of the end of such year, and a statement of cash flows for such year,
such year-end financial reports to be in reasonable detail, prepared in
accordance with generally accepted accounting principles ("GAAP"), and audited
and certified by an independent public accounting firm of nationally recognized
standing selected by the Company;

(b) as soon as practicable, but in any event within thirty (30)
days after the end of each of the first three (3) quarters of each fiscal year
of the Company, an unaudited profit or loss statement, a statement of cash flows
for such fiscal quarter and an unaudited balance sheet as of the end of such
fiscal quarter; and

(c) as soon as practicable, but in any event thirty (30) days
prior to the end of each fiscal year, a budget for the next fiscal year,
prepared on a monthly basis.

2.2 INSPECTION. The Company shall permit each Holder of at least
100,000 shares of Registrable Securities (except for a Holder reasonably deemed
by the Company to be a competitor of the Company), at such Holder's expense, to
visit and inspect the Company's properties, to examine its books of account and
records and to discuss the Company's affairs, finances and accounts with its
officers, all at such reasonable times as may be requested by the Investor;
provided, however, that the Company shall not be obligated pursuant to this
Section 2.2 to provide access to any information which it reasonably considers
to be a trade secret or similar confidential information.

2.3 TERMINATION OF COVENANTS.

(a) The covenants set forth in Sections 2.1 and 2.2 shall
terminate as to each Holder and be of no further force or effect (i) immediately
prior to the consummation of an

9
12

IPO, or (ii) when the Company shall sell, convey, or otherwise dispose of or
encumber all or substantially all of its property or business or merge into or
consolidate with any other corporation (other than a wholly-owned subsidiary
corporation) or effect any other transaction or Series of related transactions
in which more than fifty percent (50%) of the voting power of the Company is
disposed of, provided that this subsection (ii) shall not apply to a merger
effected exclusively for the purpose of changing the domicile of the
Corporation.

(b) The covenants set forth in Sections 2.1 and 2.2 shall
terminate as to each Holder and be of no further force or effect when the
Company first becomes subject to the periodic reporting requirements of Sections
13 or 15(d) of the Exchange Act, if this occurs earlier than the events
described in Section 2.3(a) above.

3. COVENANTS OF INVESTORS. The Investor may be permitted, subject to
compliance with applicable securities laws, to sell, transfer, distribute or
grant participations to another person or party with respect to any or all the
Securities in order to satisfy the requirements of the U.S. Internal Revenue
Service.

4. MISCELLANEOUS.

4.1 SUCCESSORS AND ASSIGNS. Except as otherwise provided in this
Agreement, the terms and conditions of this Agreement shall inure to the benefit
of and be binding upon the respective permitted successors and assigns of the
parties (including transferees of the Preferred Stock or any class or Series or
any Common Stock issued upon conversion thereof). Nothing in this Agreement,
express or implied, is intended to confer upon any party other than the parties
hereto or their respective successors and assigns any rights, remedies,
obligations, or liabilities under or by reason of this Agreement, except as
expressly provided in this Agreement.

4.2 AMENDMENTS AND WAIVERS. Any term of this Agreement may be amended
or waived only with the written consent of the Company and the holders of a
majority of the Registrable Securities then outstanding. Any amendment or waiver
effected in accordance with this paragraph shall be binding upon each holder of
any Registrable Securities then outstanding, each future holder of all such
Registrable Securities, and the Company.

4.3 NOTICES. Unless otherwise provided, any notice required or
permitted by this Agreement shall be in writing and shall be deemed sufficient
upon delivery, when delivered personally or by overnight courier or sent by
telegram or fax, or forty-eight (48) hours after being deposited in the U.S.
mail, as certified or registered mail, with postage prepaid, and addressed to
the party to be notified at such party's address or fax number as set forth on
the signature page or on Exhibit A, Exhibit B and Exhibit C hereto or as
subsequently modified by written notice.

4.4 SEVERABILITY. If one or more provisions of this Agreement are
held to be unenforceable under applicable law, the parties agree to renegotiate
such provision in good faith. In the event that the parties cannot reach a
mutually agreeable and enforceable replacement for such provision, then (a) such
provision shall be excluded from this Agreement, (b) the balance of

10
13

the Agreement shall be interpreted as if such provision were so excluded and (c)
the balance of the Agreement shall be enforceable in accordance with its terms.

4.5 GOVERNING LAW. This Agreement and all acts and transactions
pursuant hereto shall be governed, construed and interpreted in accordance with
the laws of the State of Washington, without giving effect to principles of
conflicts of laws.

4.6 COUNTERPARTS. This Agreement may be executed in two or more
counterparts, each of which shall be deemed an original, but all of which
together shall constitute one and the same instrument.

4.7 TITLES AND SUBTITLES. The titles and subtitles used in this
Agreement are used for convenience only and are not to be considered in
construing or interpreting this Agreement.

4.8 AGGREGATION OF STOCK. All shares of the Preferred Stock held or
acquired by affiliated entities or persons shall be aggregated together for the
purpose of determining the availability of any rights under this Agreement.

[Signature page follows]

14
EXHIBIT A

LIST OF INVESTORS - SERIES A PREFERRED

Northwest Hospital 550,700

TOTAL = 550,700

A-1

15
EXHIBIT B
LIST OF INVESTORS - SERIES B PREFERRED

ADDELCO Corporation 21,488

▇▇▇▇▇▇ ▇. ▇▇▇▇▇ and ▇▇▇▇▇▇▇▇
▇. ▇▇▇▇▇ 14,323

▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇▇ and
▇▇▇▇ ▇. ▇▇▇▇▇▇▇ 21,488

▇. ▇. ▇▇▇▇▇▇▇▇▇▇, ▇▇., TTEE 10,744

▇▇▇▇▇▇ ▇. and ▇▇▇▇ ▇. ▇▇▇▇▇ 14,323

Green Manor Corporation 42,976

J.C.E.B. Childrens Trust 14,323

▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇, III 10,738

▇▇▇▇▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇ 4,295

▇▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇ 5,732

▇▇▇▇▇ ▇. ▇▇▇▇ 14,323

▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇ 14,322

Prudential Securities C/F
▇▇▇▇▇▇ ▇▇▇▇▇-▇▇▇ Dated
08/7/98 Account #AEH-
R23495-C4 128,935

▇▇▇▇▇ Lumber Company, Inc. 42,976

▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇ MD 14,323

▇▇▇▇▇ ▇▇▇▇▇▇▇▇ and ▇▇▇▇▇ ▇.
▇▇▇▇ 14,323

▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇ and ▇▇▇▇▇ ▇.
▇▇▇▇▇▇▇ 12,891

Progress Enterprises S.A. 429,794

▇▇▇▇▇▇ ▇▇▇▇▇ 5,732

▇▇▇▇ ▇. ▇▇▇▇▇ 4,295

B-1

▇▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇ 4,295

▇▇▇▇▇ ▇. ▇▇▇▇▇▇ 21,488

Ragnvald Svino 14,323

▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇▇ and
▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇ 15,039
=======
TOTAL = 897,489

B-2

17
EXHIBIT C
LIST OF INVESTORS - SERIES C PREFERRED

AAY-TO-ZEE LP 10,000

ALCO Investment
Company 40,000

▇▇▇ ▇. ▇▇▇▇ and ▇▇▇▇▇▇▇
▇▇▇▇, Community
Property 10,000

▇▇▇▇-▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇
and ▇▇▇▇▇▇▇ ▇.
▇▇▇▇▇▇▇▇ 5,000

▇▇▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇▇▇ 10,000

▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇ 10,000

▇. ▇▇▇▇▇ Bernson and
▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇ 6,000

▇. ▇▇▇▇▇ Bernson CUST
▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇
▇▇▇▇▇▇▇ UTMA 2,000

▇. ▇▇▇▇▇ Bernson CUST
Miya ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇
UTMA 2,000

▇▇▇▇▇▇ ▇. ▇▇▇▇▇ and
▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇ 10,000

▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇ and
▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇ 20,000

▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇ C/F
▇▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇▇▇
UTMA CA 4,000

▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇ C/F
▇▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇▇▇
UTMA CA 4,000

▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇ and
▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇ 12,000

▇▇▇▇▇▇ ▇. ▇▇▇▇▇, M.D.
and ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ 5,000

C-1

The ▇▇▇▇▇▇▇▇
Revocable Trust 10,000

U. S. Bank Nat'l.
Association as Trustee of
the ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇
▇. ▇. Profit Sharing and
401(k) Plan FBO ▇▇▇▇▇
▇. ▇▇▇▇ 20,000

▇▇▇▇▇▇ ▇. ▇▇▇▇ 10,000

▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇.
and Jayn ▇▇▇▇ ▇▇▇▇▇▇ 10,000

▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇, M.D.
and ▇▇▇▇▇▇ ▇▇▇▇▇▇ 5,000

C.D.P. Partners 50,000

▇▇▇▇▇▇▇▇ Properties 10,000

1972 ▇▇▇▇▇ ▇. ▇▇▇▇▇
Trust 30,000

▇▇▇▇▇ ▇. ▇▇▇▇▇ and
▇▇▇▇▇▇ ▇. ▇▇▇▇▇ 10,000

▇▇▇▇ ▇▇▇▇▇▇ and ▇▇▇▇▇▇▇
▇▇▇▇▇▇ 5,000

▇▇▇▇▇▇ ▇▇▇▇▇▇ and
▇▇▇▇▇▇▇ ▇▇▇▇▇ 5,000

Chetron Enterprise LLP 20,000

▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇ 10,000

Coldstream Merchant
Fund I, L.P. 20,000

▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇ 240,000

▇▇▇▇ ▇. ▇▇▇▇ 5,000

▇▇▇▇▇▇▇ ▇. ▇▇▇▇, ▇▇. and
▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇ ▇▇ TEN 20,000

C-2

▇▇▇▇▇▇ ▇. ▇▇▇▇▇ 5,000

▇▇▇▇ ▇. ▇▇▇▇▇ 10,000

▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇ 10,000

▇▇▇▇ ▇▇▇▇▇▇▇▇ C/F
▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇ 13,334

▇▇▇▇ ▇▇▇▇▇▇▇▇ C/F ▇▇▇▇▇
▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇ 13,333

▇▇▇▇ ▇▇▇▇▇▇▇▇ C/F ▇▇▇▇
▇▇▇▇▇▇▇▇ 13,333

▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇▇
and ▇▇▇▇ ▇. ▇▇▇▇▇▇▇ 5,000

Dreams 4 Us 20,000

▇▇▇▇▇▇▇ ▇▇▇▇▇ Dresser
III, Custodian for
▇▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇
UTMA Texas 100

▇▇▇▇▇▇▇ ▇▇▇▇▇ Dresser
III, Custodian for ▇▇▇▇▇▇▇
▇▇▇▇▇▇▇ ▇▇ UTMA Texas 100

▇▇▇▇▇▇▇ ▇▇▇▇▇ Dresser
III, Custodian for ▇▇▇▇▇
▇. ▇▇▇▇▇▇▇ UTMA Texas 100

▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇ 20,000

▇▇▇ ▇▇▇▇▇ and ▇▇▇▇▇▇
▇▇▇▇▇ 10,000

▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇
and ▇▇▇▇▇ ▇. ▇▇▇▇▇ 3,000

▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇ and
▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇ 20,000

▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇ 10,000

▇▇▇▇ ▇▇▇▇▇▇▇▇ 10,000

C-3

▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇ 5,000

▇▇▇▇▇▇▇ ▇▇▇▇ ▇▇▇▇,
Custodian for ▇▇▇▇▇▇▇
▇▇▇▇▇▇▇ ▇▇▇▇, UTMA
Arizona 100

▇▇▇▇▇▇▇ ▇▇▇▇ ▇▇▇▇,
Custodian for ▇▇▇▇▇
▇▇▇▇ ▇▇▇▇, UTMA
Arizona 100

▇▇▇▇▇▇▇ ▇▇▇▇ ▇▇▇▇,
Custodian for ▇▇▇▇▇▇
▇▇▇▇▇▇ ▇▇▇▇, UTMA
Arizona 100

▇▇▇▇▇▇ ▇▇▇ ▇▇▇▇ and
▇▇▇▇▇▇▇ ▇▇▇▇ ▇▇▇▇ 2,500

▇.▇. ▇▇▇▇▇, ▇▇. 10,000

▇▇▇▇▇ ▇▇▇▇ ▇▇▇▇▇ 10,000

▇▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇ 10,000

▇▇▇▇ ▇▇▇▇▇▇▇▇▇
▇▇▇▇▇▇▇▇▇▇▇▇, Custodian
for Chloe ▇▇▇▇▇▇▇▇▇
▇▇▇▇▇▇▇▇▇▇▇▇ 100

▇▇▇▇▇▇▇▇ ▇. ▇▇▇ 10,000

▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇ 10,000

▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇, ▇▇. 20,000

▇▇▇▇▇ ▇. ▇▇▇▇▇▇ 20,000

▇▇▇▇ ▇. ▇▇▇▇▇ 20,000

▇▇▇▇ ▇▇▇▇▇ and ▇▇▇▇▇
▇▇▇▇▇ 88,000

▇▇▇▇▇ Capital LLC 12,000

▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇, his
separate property 40,000

▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇ 2,000

C-4

▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇ 10,000

▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇ 20,000

▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇ 20,000

▇▇▇▇▇ ▇. ▇▇▇▇▇ 10,000

▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇ III 20,000

▇▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇
and ▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇,
JTTEN 1,000

▇▇▇▇ ▇. ▇▇▇▇▇ ▇▇. 10,000

▇▇▇▇▇▇▇▇▇ ▇ ▇▇▇▇▇ 10,000

U. S. Bank Nat'l.
Association as Trustee of
the ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇
▇. ▇. Profit Sharing and
401(k) Plan FBO ▇▇▇▇▇
▇. ▇▇▇▇ 10,000

▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇ 10,000

▇▇▇▇ ▇. ▇▇▇▇▇▇▇ 20,000

▇▇▇▇▇▇▇ ▇. ▇▇▇▇ 10,000

▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇▇ 50,000

▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇ and
▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇-▇▇▇▇▇▇ 10,000

▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇ 10,000

Prudential Securities C/F
▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇ ERJ
Consulting Inc. SEP Dtd.
12/14/94, Account #066-
R53796 10,000

▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇ 10,000

▇▇▇▇▇▇ ▇▇▇▇▇ and
▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇ 2,500

C-5

▇▇▇▇ ▇. ▇▇▇▇▇ C/F ▇▇▇
▇▇▇▇▇▇▇▇ ▇▇▇▇▇ UTMA
CA 4,000

▇▇▇▇ ▇. ▇▇▇▇▇ C/F
▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇
UTMA CA 4,000

▇▇▇▇ ▇. ▇▇▇▇▇ C/F Tayte
▇▇▇▇▇▇▇▇ ▇▇▇▇▇ UTMA
CA 4,000

▇▇▇▇ ▇. ▇▇▇▇▇ 20,000

▇▇▇▇▇ ▇. ▇▇▇▇▇ 20,000

▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇, ▇▇. 20,000

Prudential Securities Inc.
C/F G. ▇▇▇▇▇ ▇▇▇▇▇▇
▇▇▇ DTD 6/1/94 20,000

▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇ 5,000

▇▇▇▇ ▇. ▇▇▇▇▇▇, ▇▇.
Testamentary Trust 20,000

R. ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇ and
▇▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇ 10,000

U.S. Bank National
Association as Trustee
for the ▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇
▇.▇. Profit Sharing and
401(k) Plan FBO ▇▇▇▇▇▇
▇. ▇▇▇▇▇▇ 5,000

▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇ 5,000

▇▇▇▇ ▇. ▇▇▇▇▇▇ and
▇▇▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇ 10,000

▇▇▇▇▇ ▇. ▇▇▇▇, Custodian
for ▇▇▇▇▇▇▇ ▇. ▇▇▇▇
UTMA California 100

▇▇▇▇▇▇ ▇. ▇▇▇▇ 20,000

C-6

▇▇▇▇▇▇ ▇▇ and ▇▇▇▇▇▇▇▇
▇▇ 10,000

▇▇▇▇ Major, Custodian
for ▇▇▇▇▇▇▇ ▇. Major UTMA
Utah 100

▇▇▇▇ Major, Custodian
for ▇▇▇▇▇ Major UTMA
Utah 100

▇▇▇▇ Major, Custodian
for ▇▇▇▇▇▇ Major UTMA
Utah 100

▇▇. ▇▇▇▇ ▇. Major and
▇▇. ▇▇▇▇ ▇. Major, JT
TEN (SS# ###-##-####) 5,000

▇▇▇ ▇▇▇▇▇▇▇▇▇ 10,000

▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇ 20,000

▇▇▇▇▇▇ International
Corp 40,000

Van ▇. ▇▇▇▇▇▇ 40,000

▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇ and
▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇ 10,000

Trust of ▇▇▇▇▇ ▇. Mercy 50,000

▇▇▇▇▇ ▇. Mercy 30,000

H. ▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇
▇▇▇, SSB ▇▇▇▇ ▇▇▇
Conversion Cust. 20,000

▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇ 2,500

▇▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇ 20,000

▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇ 10,000

▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇ 30,000

▇▇▇▇▇▇ ▇▇▇▇▇ and
▇▇▇▇▇▇▇ ▇▇▇▇▇ 4,800

C-7

▇▇▇▇ ▇. ▇▇▇ ▇▇. 10,000

▇▇▇▇ ▇. ▇▇▇▇▇ 20,000

▇▇▇▇▇▇▇ ▇. ▇'▇▇▇▇▇ and
▇▇▇▇ ▇. ▇'▇▇▇▇▇ 20,000

▇▇▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇,
Custodian for ▇▇▇▇▇▇▇ ▇.
▇▇▇▇▇ UTMA Oregon 100

▇▇▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇,
Custodian for ▇▇▇▇▇▇
▇▇▇▇▇ UTMA Oregon 100

▇▇▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇,
Custodian for ▇▇▇▇▇▇▇ ▇.
▇▇▇▇▇ UTMA Oregon 100

Bear ▇▇▇▇▇▇ Securities
Corp c/f ▇▇▇▇▇▇▇ ▇. ▇▇▇▇
▇▇▇ 10,000

Pacific Asset Partners 40,000

J. ▇▇▇▇▇ ▇▇▇▇ 20,000

▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇ 10,000

PCKKW Investments,
LLC 10,000

▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇ 12,000

▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇ and
▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇ 10,000

▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇ and
▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇ 10,000

▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇ 20,000

▇▇▇▇▇▇ ▇. ▇▇▇▇ & ▇▇▇▇
▇. ▇▇▇▇, ▇▇ TEN 10,000

▇▇▇▇▇ ▇. ▇▇▇▇▇ 80,000

C-8
25

U.S. Bank Nat'l.
Association as Trustee of
the ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇
▇.▇. Profit Sharing and
401(k) Plan FBO
▇▇▇▇▇▇▇▇ ▇. ▇▇▇▇ 10,000

▇▇▇▇▇ ▇▇▇ and ▇▇▇▇▇▇ ▇.
▇▇▇ 10,000

▇▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇ 2,000

▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇ 40,000

▇▇▇▇ ▇. ▇▇▇▇ and ▇▇▇▇▇
▇. ▇▇▇▇ 10,000

▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇ and
▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇ 20,000

▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇ 10,000

▇▇▇▇▇▇▇ ▇. ▇▇▇ 40,000

▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇▇ 5,000

▇▇▇▇▇▇ ▇▇▇▇▇▇▇ 40,000

▇▇▇▇▇ ▇▇▇▇▇▇ 10,000

▇▇ ▇▇▇▇▇▇▇ 40,000

▇▇▇▇ ▇. ▇▇▇▇ and ▇▇▇▇▇▇
▇. ▇▇▇▇ 5,000

▇▇▇▇ ▇▇▇▇ 10,000

▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇ and
▇▇▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇ 10,000

▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇, ▇▇. 20,000

▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇ and
▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇ 10,000

▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇ 40,000

▇▇▇▇▇▇/▇▇▇▇▇▇ Limited
Partnership 20,000

▇▇▇▇▇ ▇. ▇▇▇▇ 10,000

C-9
26

▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇ and
▇▇▇▇ ▇. ▇▇▇▇▇▇▇ 10,000

▇▇▇▇▇▇▇ ▇▇▇▇▇ 3,334

▇▇▇▇▇ ▇▇▇▇▇ 3,333

▇▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ 3,333

▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇ 10,000

▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇ 20,000

▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇ 10,000

▇▇▇▇ ▇. and ▇▇▇▇▇ ▇.
▇▇▇▇▇ 5,000

▇▇▇▇ ▇. ▇▇▇▇▇▇ 10,000

▇▇▇▇▇▇ ▇▇▇▇▇▇ 10,000

▇▇▇▇▇▇ ▇▇▇▇▇▇ 24,000

▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇ 5,000

Prudential Securities
▇▇▇/RO C/F ▇▇▇▇▇▇▇▇ ▇.
▇▇▇▇▇▇▇, Account #006-
R52404 10,000

▇▇▇▇ ▇. ▇▇▇▇▇▇▇ and
▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇ 10,000

C. ▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇ III 30,000

The Stusser Group 10,000

▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇ 98,000

▇▇▇▇▇▇ ▇▇▇▇▇▇▇ and
▇▇▇▇▇ ▇▇▇▇▇▇▇ 10,000

Tenwall Investment Co. 30,000

▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇ 40,000

▇▇▇▇▇▇ ▇. ▇▇▇ 5,000

C-10

▇▇▇▇▇▇ ▇. ▇▇▇ 5,000

▇▇▇ ▇. ▇▇▇▇▇▇ and
▇▇▇▇▇ ▇. ▇▇▇▇▇▇ 40,000

▇▇▇▇▇▇ ▇▇▇▇▇▇▇ and
▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇,
community property 400,000

▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇ 2,000

▇▇▇▇▇ ▇. ▇▇▇▇▇ 2,500

▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇ MD 10,000

▇▇▇▇▇ ▇. ▇▇▇▇, Custodian
for ▇▇▇▇▇▇▇▇ ▇▇▇
▇▇▇▇▇▇▇▇▇▇ UTMA
California 100

▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇ 8,000

▇▇▇▇▇▇ ▇. ▇▇▇▇▇ and
▇▇▇▇▇▇ ▇▇▇▇▇ JT TEN 10,000

▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇ 10,000

West View Partners, L.P. 20,000

▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇,
Custodian for ▇▇▇▇▇▇▇ ▇.
▇▇▇▇▇▇▇▇ UTMA Georgia 100

▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇,
Custodian for ▇▇▇▇▇▇
▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇ UTMA
Georgia 100

▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇,
Custodian for Sydney
▇▇▇▇▇ ▇▇▇▇▇▇▇▇ UTMA
Georgia 100

▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇ 5,000

▇▇▇▇▇▇ ▇▇▇▇▇▇, TTEE
fbo The ▇▇▇▇▇▇ ▇▇▇▇▇▇
401(k) Plan dtd 1/1/93 10,000

C-11
▇▇

▇▇▇▇ ▇. ▇▇▇▇▇▇ and
▇▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇ 10,000

▇▇▇▇ ▇. ▇▇▇▇▇▇ 10,000

▇▇▇▇▇▇ ▇. ▇▇▇▇ 10,000

▇▇▇▇▇▇ ▇. ▇▇▇▇, ▇▇. 10,000

▇▇▇▇▇ ▇▇▇▇▇▇ 10,000
=========
TOTAL = 3,350,600

C-12

1 EXHIBIT 10.20 NORTHWEST BIOTHERAPEUTICS, INC. AMENDED AND RESTATED INVESTORS' RIGHTS AGREEMENT

Document Metadata

Document Metadata

Table of Contents